# Mesabi Trust: financial statements, quarterly

MSB · NYSE · CIK 65172 · [Financials](/sectors/financials.md) · fiscal year ends Jan 31

Pages: [Overview](/companies/msb.md) · [Financials](/companies/msb/financials.md) · [Filings](/companies/msb/filings.md) · [Insiders](/companies/msb/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/msb/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2023 (2023-07-31) | Q3 FY2023 (2023-10-31) | Q4 FY2023 (2024-01-31) | Q1 FY2023 (2024-04-30) | Q2 FY2023 (2024-07-31) | Q3 FY2023 (2024-10-31) | Q4 FY2024 (2025-01-31) | Q1 FY2025 (2025-04-30) | Q2 FY2025 (2025-07-31) | Q3 FY2025 (2025-10-31) | Q1 FY2026 (2026-04-30) | Q2 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [9.9](/filings/0001558370-24-012612.md) | [4.9](/filings/0001558370-24-016235.md) | [6.2 d](/filings/0001558370-25-005426.md) | [6.3](/filings/0001558370-25-008570.md) | [6.5](/filings/0001104659-25-090029.md) | [79.0](/filings/0001104659-25-120673.md) | [6.9 d](/filings/0001558370-25-005426.md) | [4.7](/filings/0001104659-26-073470.md) | [5.6](/filings/0001104659-26-107085.md) | [3.6](/filings/0001104659-25-120673.md) | [2.2](/filings/0001104659-26-073470.md) | [2.5](/filings/0001104659-26-107085.md) |
| Cost of revenue | $m | [0.7](/filings/0001558370-24-012612.md) | [0.8](/filings/0001558370-24-016235.md) | [1.5 d](/filings/0001558370-25-005426.md) | [2.8](/filings/0001558370-25-008570.md) | [1.1](/filings/0001104659-25-090029.md) | [0.7](/filings/0001104659-25-120673.md) | [0.8 d](/filings/0001558370-25-005426.md) | [1.1](/filings/0001104659-26-073470.md) | [0.9](/filings/0001104659-26-107085.md) | [0.8](/filings/0001104659-25-120673.md) | [1.2](/filings/0001104659-26-073470.md) | [2.6](/filings/0001104659-26-107085.md) |
| Net income | $m | [9.2](/filings/0001558370-24-012612.md) | [4.1](/filings/0001558370-24-016235.md) | [4.7 d](/filings/0001558370-25-005426.md) | [3.5](/filings/0001558370-25-008570.md) | [5.4](/filings/0001104659-25-090029.md) | [78.3](/filings/0001104659-25-120673.md) | [6.1 d](/filings/0001558370-25-005426.md) | [3.6](/filings/0001104659-26-073470.md) | [4.7](/filings/0001104659-26-107085.md) | [2.8](/filings/0001104659-25-120673.md) | [1.1](/filings/0001104659-26-073470.md) | [(0.1)](/filings/0001104659-26-107085.md) |
| Basic EPS | $ per share | [0.70](/filings/0001558370-24-012612.md) | [0.31](/filings/0001558370-24-016235.md) | not reported | [0.27](/filings/0001558370-25-008570.md) | [0.41](/filings/0001104659-25-090029.md) | [5.97](/filings/0001104659-25-120673.md) | not reported | [0.28](/filings/0001104659-26-073470.md) | [0.36](/filings/0001104659-26-107085.md) | [0.21](/filings/0001104659-25-120673.md) | [0.08](/filings/0001104659-26-073470.md) | [(0.01)](/filings/0001104659-26-107085.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Net income: us-gaap:NetIncomeLoss
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-10-31) | FY2023 (2024-01-31) | Q1 FY2023 (2024-04-30) | Q2 FY2023 (2024-07-31) | Q3 FY2023 (2024-10-31) | FY2024 (2025-01-31) | Q1 FY2025 (2025-04-30) | Q2 FY2025 (2025-07-31) | Q3 FY2025 (2025-10-31) | period not labelled (2026-01-31) | Q1 FY2026 (2026-04-30) | Q2 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current assets | $m | [26.0](/filings/0001558370-23-019801.md) | [26.7](/filings/0001558370-25-005426.md) | [25.1](/filings/0001558370-24-009141.md) | [26.2](/filings/0001558370-24-012612.md) | [101](/filings/0001558370-24-016235.md) | [102](/filings/0001104659-25-120673.md) | [27.4](/filings/0001558370-25-008570.md) | [24.8](/filings/0001104659-25-090029.md) | [26.0](/filings/0001104659-25-120673.md) | [24.4](/filings/0001104659-26-107085.md) | [21.9](/filings/0001104659-26-073470.md) | [19.8](/filings/0001104659-26-107085.md) |
| Total assets | $m | [26.0](/filings/0001558370-23-019801.md) | [26.7](/filings/0001558370-25-005426.md) | [25.1](/filings/0001558370-24-009141.md) | [26.2](/filings/0001558370-24-012612.md) | [101](/filings/0001558370-24-016235.md) | [102](/filings/0001104659-25-120673.md) | [27.4](/filings/0001558370-25-008570.md) | [24.8](/filings/0001104659-25-090029.md) | [26.0](/filings/0001104659-25-120673.md) | [24.4](/filings/0001104659-26-107085.md) | [21.9](/filings/0001104659-26-073470.md) | [19.8](/filings/0001104659-26-107085.md) |
| Total liabilities | $m | [4.9](/filings/0001558370-23-019801.md) | [5.7](/filings/0001558370-25-005426.md) | [4.5](/filings/0001558370-24-009141.md) | [4.1](/filings/0001558370-24-012612.md) | [5.3](/filings/0001558370-24-016235.md) | [78.4](/filings/0001104659-25-120673.md) | [7.8](/filings/0001558370-25-008570.md) | [2.0](/filings/0001104659-25-090029.md) | [4.9](/filings/0001104659-25-120673.md) | [4.0](/filings/0001104659-26-107085.md) | [3.6](/filings/0001104659-26-073470.md) | [2.3](/filings/0001104659-26-107085.md) |
| Shareholders' equity | $m | [21.1](/filings/0001558370-24-016235.md) | [21.0](/filings/0001104659-25-120673.md) | [20.7](/filings/0001104659-25-090029.md) | [22.1](/filings/0001104659-25-120673.md) | [95.3](/filings/0001104659-25-120673.md) | [23.3](/filings/0001104659-26-107085.md) | [19.6](/filings/0001104659-26-107085.md) | [22.8](/filings/0001104659-26-107085.md) | [21.1](/filings/0001104659-25-120673.md) | [20.4](/filings/0001104659-26-107085.md) | [18.3](/filings/0001104659-26-107085.md) | [17.6](/filings/0001104659-26-107085.md) |

- Cash and equivalents: not reported
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q2 FY2023 (2023-07-31) | Q3 FY2023 (2023-10-31) | Q4 FY2023 (2024-01-31) | Q1 FY2023 (2024-04-30) | Q2 FY2023 (2024-07-31) | Q3 FY2023 (2024-10-31) | Q4 FY2024 (2025-01-31) | Q1 FY2025 (2025-04-30) | Q2 FY2025 (2025-07-31) | Q3 FY2025 (2025-10-31) | Q1 FY2026 (2026-04-30) | Q2 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [4.6 d](/filings/0001558370-24-012612.md) | [5.2 d](/filings/0001558370-24-016235.md) | [5.7 d](/filings/0001558370-25-005426.md) | [2.5](/filings/0001558370-25-008570.md) | [3.8 d](/filings/0001104659-25-090029.md) | [78.2 d](/filings/0001104659-25-120673.md) | [9.4 d](/filings/0001558370-25-005426.md) | [2.1](/filings/0001104659-26-073470.md) | [4.4 d](/filings/0001104659-26-107085.md) | [3.5 d](/filings/0001104659-25-120673.md) | [0.5](/filings/0001104659-26-073470.md) | [0.2 d](/filings/0001104659-26-107085.md) |
| Dividends paid | $m | not reported | not reported | not reported | [4.9](/filings/0001558370-25-008570.md) | [3.8 d](/filings/0001104659-25-090029.md) | [3.9 d](/filings/0001104659-25-120673.md) | [5.1 d](/filings/0001558370-25-005426.md) | [78.1](/filings/0001104659-26-073470.md) | [7.3 d](/filings/0001104659-26-107085.md) | [1.6 d](/filings/0001104659-25-120673.md) | [3.4](/filings/0001104659-26-073470.md) | [3.1 d](/filings/0001104659-26-107085.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends

Shares outstanding: 13,120,010 at 2026-09-11, from the cover of the [10-Q filed 2026-09-11](/filings/0001104659-26-107085.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:19 ET. No prices; not investment advice.